Vertellus Biomaterials is a business unit of Vertellus Specialties UK Ltd, which is part of the Plastics business of Vertellus LLC. It is our aim to work with our partners to supply biocompatible materials to improve the clinical performance of medical devices, thereby improving the patient's quality of life.
Vertellus LLC is a progressive, modern company committed to providing value to its customers through leading technology and contemporary business systems and processes. The company was formed in July of 2006 through a merger of Reilly Industries and Rutherford Chemicals.
At the same time, Vertellus Specialties UK Ltd (formerly Seal Sands Chemicals Ltd, a part of Rutherford Chemicals) reached an agreement with Biocompatibles UK Ltd to licence its biocompatible polymer technology based on phosphorylcholine (PC) derivatives. Excluding certain rights already granted, the transaction included specific patent and know-how rights, trademarks, process technology and business relationships associated with PC Technology™. Key commercial and technical personnel also moved from Biocompatibles to join Vertellus.
This was an excellent fit for Vertellus, which has been commercially producing PC materials for a number of years and allows the newly formed Vertellus Biomaterials unit to leverage the company’s manufacturing and marketing strengths.
While the main focus area for Vertellus Biomaterials continues to be medical device and drug delivery applications, Vertellus is also investing in novel materials for new applications outside of healthcare.